Bio-Rad Laboratories Inc (BIO) Wheel Strategy

Running a BIO wheel strategy lets you generate consistent premium income on Bio-Rad Laboratories Inc while setting your own entry and exit prices on the underlying. Bio-Rad Laboratories Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own BIO, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best BIO wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on BIO, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable BIO wheel from a losing one.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the BIO wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your BIO wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.